Early research (Phase 1)Ended earlyNCT06364696What this trial is testingFind a Suitable Dose of ASP4396 in Adults With Solid TumorsWho this might be right forSolid Tumor Astellas Pharma Inc 60
Testing effectiveness (Phase 2)Study completedNCT02653313What this trial is testingParvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic CancerWho this might be right forCarcinoma, Pancreatic Ductal Oryx GmbH & Co. KG 7
Testing effectiveness (Phase 2)UnknownNCT04692740What this trial is testingChlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial)Who this might be right forPancreatic Ductal Adenocarcinoma Michele Reni 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04888312What this trial is testingSafety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer PatientsWho this might be right forMetastatic Pancreatic Ductal Adenocarcinoma Alligator Bioscience AB 94
Testing effectiveness (Phase 2)Study completedNCT01658943What this trial is testingSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyWho this might be right forPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more National Cancer Institute (NCI) 137
Very early researchLooking for participantsNCT07089940What this trial is testingOMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+2 more OHSU Knight Cancer Institute 12
Not applicableStudy completedNCT00132704What this trial is testingAn Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationWho this might be right forOvarian NeoplasmsColorectal NeoplasmsMelanoma+2 more Memorial Sloan Kettering Cancer Center 149
Testing effectiveness (Phase 2)Active Not RecruitingNCT06168812What this trial is testingGlipizide to Treat High Blood Sugar in People With Pancreatic CancerWho this might be right forPancreatic CancerPancreatic CarcinomaPancreatic Ductal Adenocarcinoma+3 more Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT05642962What this trial is testingPancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Who this might be right forMetastatic Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma+10 more Memorial Sloan Kettering Cancer Center 17
Large-scale testing (Phase 3)Looking for participantsNCT06079346What this trial is testingOT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma Oncotelic Inc. 455
Large-scale testing (Phase 3)Looking for participantsNCT07621718What this trial is testingStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Who this might be right forPancreatic CancerPancreatic Cancer MetastaticPDAC+5 more Revolution Medicines, Inc. 670
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613What this trial is testingCediranib in Combination With Olaparib in Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more National Cancer Institute (NCI) 122
Testing effectiveness (Phase 2)Study completedNCT04493060What this trial is testingNiraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Ductal AdenocarcinomaStage IV Pancreatic Cancer AJCC v8 Mayo Clinic 22
Testing effectiveness (Phase 2)Study completedNCT04752696What this trial is testingOnvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Adenocarcinoma Cardiff Oncology 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666740What this trial is testingPembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based TherapyWho this might be right forMetastatic Pancreatic Ductal AdenocarcinomaHomologous Recombination Deficiency (HRD) Memorial Sloan Kettering Cancer Center 63
Early research (Phase 1)Study completedNCT04292743What this trial is testingEryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal AdenocarcinomaWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal Adenocarcinoma Georgetown University 19
Testing effectiveness (Phase 2)UnknownNCT03666832What this trial is testingMulti-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-PaclitaxelWho this might be right forMetastatic Pancreatic Cancer Joon Oh Park 36
Testing effectiveness (Phase 2)WithdrawnNCT02575508What this trial is testingPan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWho this might be right forColon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more Roswell Park Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT02715804What this trial is testingPEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal AdenocarcinomaWho this might be right forPancreatic Ductal Carcinoma Halozyme Therapeutics 492
Testing effectiveness (Phase 2)Looking for participantsNCT07483983What this trial is testingStudy Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/ResistanceWho this might be right forMetastatic/Locally Advanced Non-Small-Cell Lung CancerMetastatic/Locally Pancreatic Ductal Adenocarcinoma Gustave Roussy, Cancer Campus, Grand Paris 60